Compile Data Set for Download or QSAR
Report error Found 153 of affinity data for UniProtKB/TrEMBL: P05231
TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM419193(US10457681, Compound Ia-01 | US10487084, Compound ...)
Affinity DataEC50:  108nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Tech-nologies clear, V-bottom 384-well plate using ECHO acoustic liquid ha...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM419194(US10457681, Compound Ia-02 | US10487084, Compound ...)
Affinity DataEC50:  12.6nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Tech-nologies clear, V-bottom 384-well plate using ECHO acoustic liquid ha...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM419208(US10457681, Compound Ia-03 | US10487084, Compound ...)
Affinity DataEC50:  15nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Tech-nologies clear, V-bottom 384-well plate using ECHO acoustic liquid ha...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM419219(US10457681, Compound Ia-04 | US10487084, Compound ...)
Affinity DataEC50:  6.90nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Tech-nologies clear, V-bottom 384-well plate using ECHO acoustic liquid ha...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM419243(US10457681, Compound Ia-05 | US10487084, Compound ...)
Affinity DataEC50:  39.7nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Tech-nologies clear, V-bottom 384-well plate using ECHO acoustic liquid ha...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM419258(US10457681, Compound Ia-06 | US10487084, Compound ...)
Affinity DataEC50:  88.7nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Tech-nologies clear, V-bottom 384-well plate using ECHO acoustic liquid ha...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM420040(US10487084, Compound Ib-01)
Affinity DataEC50:  106nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Tech-nologies clear, V-bottom 384-well plate using ECHO acoustic liquid ha...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM420041(US10487084, Compound Ib-02)
Affinity DataEC50:  7.55nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Tech-nologies clear, V-bottom 384-well plate using ECHO acoustic liquid ha...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM420042(US10487084, Compound Ic-01)
Affinity DataEC50:  365nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Tech-nologies clear, V-bottom 384-well plate using ECHO acoustic liquid ha...More data for this Ligand-Target Pair
Ligand InfoSimilars
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM419193(US10457681, Compound Ia-01 | US10487084, Compound ...)
Affinity DataEC50:  250nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM419194(US10457681, Compound Ia-02 | US10487084, Compound ...)
Affinity DataEC50:  4.90nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM419208(US10457681, Compound Ia-03 | US10487084, Compound ...)
Affinity DataEC50:  14.4nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM419219(US10457681, Compound Ia-04 | US10487084, Compound ...)
Affinity DataEC50:  48nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM419258(US10457681, Compound Ia-06 | US10487084, Compound ...)
Affinity DataEC50:  750nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423474(US10508115, Compound Ia-05 | US10508115, Compound ...)
Affinity DataEC50:  506nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423476(US10508115, Compound Ia-03)
Affinity DataEC50:  17.6nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423477(US10508115, Compound Ia-04)
Affinity DataEC50:  10.4nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423474(US10508115, Compound Ia-05 | US10508115, Compound ...)
Affinity DataEC50:  31nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423479(US10508115, Compound Ia-06)
Affinity DataEC50:  17.3nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423480(US10508115, Compound Ia-07)
Affinity DataEC50:  6.62nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423481(US10508115, Compound Ia-08)
Affinity DataEC50:  24.3nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423482(US10508115, Compound Ib-01)
Affinity DataEC50:  104nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423483(US10508115, Compound Ib-02)
Affinity DataEC50:  29.6nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423484(US10508115, Compound Ib-03)
Affinity DataEC50:  7.5nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423486(US10508115, Compound Ib-05)
Affinity DataEC50:  9.57nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423487(US10508115, Compound Ib-06)
Affinity DataEC50:  10.7nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423488(US10508115, Compound Ib-07)
Affinity DataEC50:  5.81nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423490(US10508115, Compound Ib-09)
Affinity DataEC50:  5.91nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423491(US10508115, Compound Ib-10)
Affinity DataEC50:  14.3nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423492(US10508115, Compound Ib-11)
Affinity DataEC50:  8.14nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423493(US10508115, Compound Ib-12)
Affinity DataEC50:  3.77nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423494(US10508115, Compound Ib-13)
Affinity DataEC50:  30.9nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423495(US10508115, Compound Ib-14)
Affinity DataEC50:  18.9nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423496(US10508115, Compound Ib-17 | US10508115, Compound ...)
Affinity DataEC50:  64.7nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423497(US10508115, Compound Ib-16)
Affinity DataEC50:  84.8nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423496(US10508115, Compound Ib-17 | US10508115, Compound ...)
Affinity DataEC50:  5.11nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423499(US10508115, Compound Ic-01)
Affinity DataEC50:  10.1nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423500(US10508115, Compound Ic-02)
Affinity DataEC50:  16.1nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423501(US10508115, Compound Ic-03)
Affinity DataEC50:  78nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423502(US10508115, Compound Ic-04)
Affinity DataEC50:  20.7nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423503(US10508115, Compound Ic-05)
Affinity DataEC50:  44.2nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423504(US10508115, Compound Ic-06)
Affinity DataEC50:  28nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423505(US10508115, Compound Ic-07)
Affinity DataEC50:  133nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423506(US10508115, Compound Ic-08)
Affinity DataEC50:  232nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423507(US10508115, Compound Id-01)
Affinity DataEC50:  28nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423508(US10508115, Compound Id-02)
Affinity DataEC50:  25nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423509(US10508115, Compound Id-03)
Affinity DataEC50:  14nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423510(US10508115, Compound Id-04)
Affinity DataEC50:  13nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423511(US10508115, Compound Id-05)
Affinity DataEC50:  12nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-6(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM423512(US10508115, Compound Id-06)
Affinity DataEC50:  100nMAssay Description:Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Displayed 1 to 50 (of 153 total ) | Next | Last >>
Jump to: